Data updated: Mar 10, 2026
ALBENDAZOLE
ALBENDAZOLE
Approved 2018-09-21
9
Indications
--
Phase 3 Trials
7
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2018-09-21
- Routes
- ORAL
- Dosage Forms
- TABLET
ALBENDAZOLE Approval History
Loading approval history...
What ALBENDAZOLE Treats
9 FDA approvalsOriginally approved for its first indication in 2018 . Covers 9 distinct patient populations.
- Other (9)
Other
(9 approvals)- • Approved indication (Sep 2018)Letter
- • Approved indication (Dec 2018)
- • Approved indication (Dec 2018)
- • Approved indication (May 2019)
- • Approved indication (May 2019)
- • Approved indication (Jun 2020)
- • Approved indication (Jan 2021)
- • Approved indication (Jan 2021)
- • Approved indication (Sep 2024)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ALBENDAZOLE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.